Thoracentesis to Alleviate Cardiac Pleural Effusion
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The present study will examine the comparative effectiveness of two treatment strategies
currently used in the treatment of patients with systolic heart failure presenting with
pleural effusion. Patients will be randomized to standard medical treatment only or medical
treatment and referral to thoracentesis.
Study hypothesis: A strategy of referring patients with heart failure-related pleural
effusion to thoracentesis increases number of days alive outside of hospital over the
following 90 days.
Phase:
N/A
Details
Lead Sponsor:
Bispebjerg Hospital
Collaborators:
Hartmann Fonden Independent Research Fund Denmark University Hospital Bispebjerg and Frederiksberg